A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/1997
10/29/1997	EP0802899A1 Enantiomers of 1-(3,4-dichlorobenzyl)-2-methylaminoindane
10/29/1997	EP0802800A2 Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
10/29/1997	EP0802797A1 Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis
10/29/1997	EP0493380B1 Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs
10/28/1997	US5681965 Alpha-phenyl tert-butyl nitrone and derivatives as free radical scavengers treating aging, oxidative tissue damage
10/28/1997	US5681590 Dry mix formulation for bisphosphonic acids
10/23/1997	WO1997039032A1 Ligand inhibitors of insulin-like growth factor binding proteins and methods of use therefor
10/23/1997	WO1997038986A1 Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors
10/23/1997	WO1997038709A1 Use of growth hormone
10/23/1997	WO1997038593A1 Diabetic supplement bar
10/23/1997	WO1997026853A3 Dna encoding galanin galr2 receptors and uses thereof
10/23/1997	DE19615812A1 Pharmazeutische Zubereitung enthaltend Diphosphonsäuren zur oralen Applikation Pharmaceutical preparation for oral administration containing diphosphonic acids
10/23/1997	CA2250907A1 Use of growth hormone
10/23/1997	CA2224859A1 Ligand inhibitors of insulin-like growth factor binding proteins and methods of use therefor
10/22/1997	EP0801562A1 Pharmaceutical composition containing fenofibrate and polyglycolized glycerides
10/22/1997	EP0801557A2 LIPOSOME FORMULATIONS OF 5$g(b) STEROIDS
10/21/1997	US5679809 Concentrate of polyunsaturated fatty acid ethyl esters and preparation thereof
10/21/1997	US5679782 Inhibit receptor binding activity of urokinase-type plasminogen activator
10/21/1997	US5679717 Method for removing bile salts from a patient with alkylated amine polymers
10/21/1997	US5679704 Use of 2- (N-(2-aminoethyl)amino) acetic acid derivatives
10/21/1997	US5679650 Pharmaceutical compositions including mixtures of an adenosine compound and a catecholamine
10/21/1997	US5679339 Method of using IL-11 for treating spondyloarthropies
10/16/1997	WO1997038100A1 Human cachexia associated protein
10/16/1997	WO1997038084A2 Polynucleotides derived from a pbmc cdna library encoding secreted proteins
10/16/1997	WO1997038004A1 Gene family associated with neurosensory defects
10/16/1997	WO1997037998A2 Neuropeptide y receptor y5 and nucleic acid sequence
10/16/1997	WO1997037972A1 Novel vitamin d analogues
10/16/1997	WO1997037688A2 Pharmaceutical combination containing a compound having angiotensin ii and antagonistic activity
10/16/1997	WO1997037681A1 Medicament for optimising mucosal viscosity and stimulating intestinal function
10/16/1997	WO1997037664A2 Use of 7 alpha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders
10/16/1997	WO1997037656A1 Anticachectic composition
10/16/1997	CA2650637A1 Pharmaceutical composition containing angiotensin ii antagonist
10/16/1997	CA2251603A1 Gene family associated with neurosensory defects
10/16/1997	CA2251009A1 Medicament for optimising mucosal viscosity and stimulating intestinal function
10/16/1997	CA2250874A1 Use of 7 alpha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders
10/16/1997	CA2250868A1 Human cachexia associated protein
10/16/1997	CA2250860A1 Polynucleotides encoding secreted proteins
10/16/1997	CA2250722A1 Neuropeptide y receptor y5 and nucleic acid sequence
10/15/1997	EP0801060A1 Heterocyclic Beta-3 Adrenergenic Agonists
10/15/1997	EP0800826A2 Apoptosis-controlling agent
10/15/1997	EP0800824A1 Stable carotenoid emulsions for parenteral administration
10/15/1997	EP0800584A1 Arachidonic acid and methods for the production and use thereof
10/15/1997	EP0800580A1 Method and reagent for prevention, inhibition of progression and regression of vascular diseases
10/15/1997	EP0800534A2 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases
10/15/1997	EP0800517A1 Acetylenes disubstituted with a 5 or 8 substituted tetrahydronaphthyl or dihydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity
10/15/1997	EP0800503A1 Novel trienoic retinoid compounds and methods
10/15/1997	EP0800405A1 Continuous low-dose administration of parathyroid hormone or its agonist
10/15/1997	EP0800401A1 Medicinal composition for diabetes
10/15/1997	EP0800397A1 Bone mass anabolic composition comprising olpadronate
10/15/1997	EP0800391A1 Benzimidazoles as inhibitors of calcitriol metabolism
10/15/1997	EP0654032B1 Quinuclidine derivatives as squalene synthase inhibitors
10/15/1997	CN1162311A Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
10/15/1997	CN1161851A Medicine for treating diabetes
10/14/1997	US5677342 Phenoxy acetic acids as aldose reductase inhibitors and antihyperglycemic agents
10/14/1997	US5677341 Mixture with lipid, nonionic surfactants and cholesterol
10/14/1997	US5677322 Therapy for aging, diabetes
10/14/1997	US5677320 Phenyl or heteroaryl and tetrahydronaphthyl substituted diene compounds having retinoid like biological activity
10/14/1997	US5677319 Thiazole derivative
10/14/1997	US5677298 Benzoxazepine-2-one compounds and their use
10/14/1997	US5676965 Use of polydeoxyribonucleotides in diabetic neuropathies
10/14/1997	US5676943 Nerve growth factor
10/09/1997	WO1997036927A1 Amphipathic molecules as cholesterol and other lipid uptake inhibitors
10/09/1997	WO1997036871A1 6-phenylpyridyl-2-amine derivatives
10/09/1997	WO1997036867A1 Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-ht1a- and/or 5-ht1d receptors
10/09/1997	WO1997036861A1 Meta-substituted phenylene sulphonamide derivatives
10/09/1997	WO1997036860A1 Cinnamic acid derivatives and their use as integrin antagonists
10/09/1997	WO1997036858A1 Cyclopropyl alkanoic acid derivatives
10/09/1997	WO1997036601A1 Cyclic peptide vaccines for treatment and prevention of diabetes
10/09/1997	WO1997036594A1 Vitamin b2-containing medicines
10/09/1997	WO1997036497A2 Cocoa extract compounds and methods for making and using the same
10/09/1997	WO1997032022A3 Canine ob protein compositions and methods
10/09/1997	CA2788661A1 Preparation of microbial polyunsaturated fatty acid containing oil from pasteurised biomass
10/09/1997	CA2250814A1 Cyclic peptide vaccines for treatment and prevention of diabetes
10/09/1997	CA2250695A1 Cyclopropyl alkanoic acid derivatives
10/09/1997	CA2250690A1 Cinnamic acid derivatives and their use as integrin antagonists
10/09/1997	CA2249603A1 Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-ht1a- and/or 5-ht1d receptors
10/09/1997	CA2249459A1 Amphipathic molecules as cholesterol and other lipid uptake inhibitors
10/09/1997	CA2201988A1 Heterocyclic .beta.-adrenergic agonists
10/08/1997	EP0799200A1 Substituted azetidin-2-ones for treatment of atherosclerosis
10/08/1997	EP0799041A1 Estrogen compositions and method for neuroprotection
10/08/1997	EP0799037A1 Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
10/08/1997	EP0799035A1 Emulsion suitable for administering a sphingolipid and use thereof
10/08/1997	EP0506892B1 Boronated nucleosides
10/08/1997	CN1161695A Apolioprotein-B synthesis inhibitors
10/08/1997	CN1161647A Compositions and method for controlling smoking
10/08/1997	CN1161328A Aminoalkyl subsetd. benzo-heterocyclic compounds
10/07/1997	US5674896 Triglycerides having stearic acid residue at 2-position and other fatty acid residues containing two to ten carbons at the 1- and 3-positions, for mixing with foods or replacing other fat or oils
10/07/1997	US5674893 Method for preventing reducing or risk of onset of cerebrovascular events employing an HMG CoA reductase inhibitor
10/07/1997	US5674862 Methods of treating diabetic mellitus and its complications
10/07/1997	US5674853 Containing dietary polyunsaturated fatty acids and a saponin
10/07/1997	US5674845 Administering insulin-like growth factor(somatomedins)
10/07/1997	US5674681 Detecting association of a nonclassical major histocompatibility complex with a beta2 microglobin
10/07/1997	US5674531 Nanoparticles containing an active substance and a ketalized polytartramidic acid, process for their preparation, and use thereof
10/07/1997	US5674498 Blood-lipid depressant and victuals containing the same
10/02/1997	WO1997035875A1 Peptide for inhibiting blood triglyceride level rise and inhibitor for blood triglyceride level rise comprising the peptide as active ingredient
10/02/1997	WO1997035862A1 Azaspiroderivatives
10/02/1997	WO1997035861A1 Azaspiro derivatives
10/02/1997	WO1997035852A1 Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents
10/02/1997	WO1997035620A1 Formulations of ob protein
10/02/1997	WO1997035608A1 Diabetes treatment

1 ... 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 ... 1298